Stock listing
KRX:087010 Peptron, Inc. (펩트론) 주가
Follow Peptron, Inc. into a list and get an email when it puts out news.
Share price · KRX:087010
₩86,000 KRW +1,900 (+2.3%)
Close on Nov 20, 2026
- Day range
- ₩84,900 – ₩89,800 KRWNov 20, 2026
- Volume
- 110,556 sharesNov 20, 2026
- Market cap
- ₩1.32T KRWAt the close on Nov 20, 2026 · price × 15.33M shares outstanding
- 52-week range
- ₩79,200 – ₩381,500 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩22.09B KRWMedian day 145,683 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:087010 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩86,000 | +1,900 | +2.3% | ₩85,900 | ₩89,800 | ₩84,900 | 110,556 | |
| ₩84,100 | -5,100 | -5.7% | ₩89,600 | ₩91,800 | ₩83,200 | 200,520 | |
| ₩89,200 | +700 | +0.8% | ₩88,100 | ₩92,100 | ₩86,800 | 103,792 | |
| ₩88,500 | -4,200 | -4.5% | ₩94,000 | ₩94,500 | ₩87,600 | 119,363 | |
| ₩92,700 | -4,300 | -4.4% | ₩98,000 | ₩101,200 | ₩92,100 | 147,445 | |
| ₩97,000 | -2,100 | -2.1% | ₩99,000 | ₩99,200 | ₩94,100 | 115,508 | |
| ₩99,100 | +5,700 | +6.1% | ₩92,800 | ₩101,300 | ₩92,300 | 193,426 | |
| ₩93,400 | +100 | +0.1% | ₩96,100 | ₩96,600 | ₩91,500 | 97,834 | |
| ₩93,300 | -4,000 | -4.1% | ₩97,200 | ₩98,700 | ₩88,600 | 151,862 | |
| ₩97,300 | +3,600 | +3.8% | ₩86,800 | ₩100,000 | ₩85,500 | 213,675 | |
| ₩93,700 | 0 | 0.0% | ₩98,600 | ₩100,300 | ₩91,000 | 159,765 | |
| ₩93,700 | -3,200 | -3.3% | ₩97,800 | ₩99,300 | ₩90,700 | 187,386 | |
| ₩96,900 | +2,100 | +2.2% | ₩94,700 | ₩100,300 | ₩93,300 | 123,518 | |
| ₩94,800 | +2,500 | +2.7% | ₩92,100 | ₩97,300 | ₩91,600 | 103,509 | |
| ₩92,300 | -4,900 | -5.0% | ₩96,800 | ₩97,500 | ₩90,300 | 147,605 | |
| ₩97,200 | 0 | 0.0% | ₩98,300 | ₩99,500 | ₩95,300 | 123,201 | |
| ₩97,200 | +1,600 | +1.7% | ₩94,600 | ₩98,000 | ₩93,400 | 161,948 | |
| ₩95,600 | -2,700 | -2.7% | ₩99,300 | ₩102,300 | ₩94,300 | 155,109 | |
| ₩98,300 | -6,200 | -5.9% | ₩100,000 | ₩100,600 | ₩90,200 | 156,854 | |
| ₩104,500 | +2,200 | +2.2% | ₩99,800 | ₩105,700 | ₩98,200 | 123,959 | |
| ₩102,300 | -3,300 | -3.1% | ₩107,000 | ₩110,700 | ₩100,700 | 140,166 | |
| ₩105,600 | +4,400 | +4.3% | ₩99,800 | ₩107,500 | ₩99,500 | 226,690 | |
| ₩101,200 | +400 | +0.4% | ₩99,200 | ₩101,600 | ₩94,700 | 175,597 | |
| ₩100,800 | +1,600 | +1.6% | ₩99,400 | ₩109,300 | ₩97,900 | 267,645 | |
| ₩99,200 | +10,900 | +12.3% | ₩88,800 | ₩103,000 | ₩87,400 | 400,709 | |
| ₩88,300 | -1,100 | -1.2% | ₩86,200 | ₩93,500 | ₩85,400 | 299,067 | |
| ₩89,400 | +6,500 | +7.8% | ₩87,000 | ₩94,000 | ₩85,300 | 398,304 | |
| ₩82,900 | -6,600 | -7.4% | ₩85,900 | ₩86,200 | ₩79,200 | 342,106 | |
| ₩89,500 | -2,000 | -2.2% | ₩88,600 | ₩94,000 | ₩86,500 | 468,064 | |
| ₩91,500 | -39,100 | -29.9% | ₩98,300 | ₩99,100 | ₩91,500 | 600,660 | |
| ₩130,600 | 0 | 0.0% | ₩130,800 | ₩136,500 | ₩125,550 | 1,151,621 | |
| ₩130,600 | +1,100 | +0.8% | ₩128,300 | ₩133,300 | ₩127,100 | 143,920 | |
| ₩129,500 | -13,000 | -9.1% | ₩142,600 | ₩145,200 | ₩129,400 | 212,922 | |
| ₩142,500 | +10,900 | +8.3% | ₩131,200 | ₩142,600 | ₩130,400 | 162,879 | |
| ₩131,600 | -300 | -0.2% | ₩130,000 | ₩135,900 | ₩127,400 | 114,863 | |
| ₩131,900 | -5,400 | -3.9% | ₩134,300 | ₩135,300 | ₩125,100 | 203,820 | |
| ₩137,300 | -8,200 | -5.6% | ₩144,200 | ₩150,900 | ₩137,200 | 130,370 | |
| ₩145,500 | +3,500 | +2.5% | ₩143,400 | ₩148,400 | ₩142,600 | 90,241 | |
| ₩142,000 | -19,400 | -12.0% | ₩158,600 | ₩158,600 | ₩141,700 | 244,757 | |
| ₩161,400 | +5,400 | +3.5% | ₩160,100 | ₩162,000 | ₩158,000 | 73,104 | |
| ₩156,000 | +8,100 | +5.5% | ₩150,600 | ₩156,000 | ₩149,100 | 108,280 | |
| ₩147,900 | +1,400 | +1.0% | ₩147,800 | ₩152,700 | ₩145,900 | 61,535 | |
| ₩146,500 | -4,300 | -2.9% | ₩148,500 | ₩148,800 | ₩142,200 | 104,915 | |
| ₩150,800 | +11,700 | +8.4% | ₩146,700 | ₩155,000 | ₩142,000 | 190,400 | |
| ₩139,100 | -6,900 | -4.7% | ₩141,800 | ₩143,000 | ₩138,100 | 117,702 | |
| ₩146,000 | -5,600 | -3.7% | ₩144,900 | ₩148,400 | ₩144,400 | 75,828 | |
| ₩151,600 | +5,100 | +3.5% | ₩143,400 | ₩151,600 | ₩141,200 | 231,876 | |
| ₩146,500 | -700 | -0.5% | ₩145,500 | ₩150,000 | ₩144,100 | 111,077 | |
| ₩147,200 | -13,000 | -8.1% | ₩160,200 | ₩160,300 | ₩147,200 | 192,415 | |
| ₩160,200 | +2,900 | +1.8% | ₩161,300 | ₩167,500 | ₩155,500 | 92,872 | |
| ₩157,300 | +10,700 | +7.3% | ₩148,000 | ₩162,400 | ₩147,400 | 129,115 | |
| ₩146,600 | -10,900 | -6.9% | ₩158,900 | ₩160,200 | ₩145,300 | 157,579 | |
| ₩157,500 | -8,000 | -4.8% | ₩157,500 | ₩168,600 | ₩154,200 | 166,265 | |
| ₩165,500 | -17,700 | -9.7% | ₩180,200 | ₩183,100 | ₩161,500 | 217,107 | |
| ₩183,200 | -9,200 | -4.8% | ₩192,300 | ₩192,500 | ₩176,200 | 143,743 | |
| ₩192,400 | +4,200 | +2.2% | ₩185,500 | ₩192,900 | ₩184,700 | 87,102 | |
| ₩188,200 | +3,200 | +1.7% | ₩180,200 | ₩189,800 | ₩180,200 | 79,415 | |
| ₩185,000 | +1,800 | +1.0% | ₩184,400 | ₩189,800 | ₩183,500 | 78,805 | |
| ₩183,200 | +300 | +0.2% | ₩179,600 | ₩184,100 | ₩174,400 | 90,921 | |
| ₩182,900 | +4,300 | +2.4% | ₩178,700 | ₩186,000 | ₩176,600 | 109,169 | |
| ₩178,600 | -7,300 | -3.9% | ₩181,900 | ₩183,400 | ₩175,600 | 102,502 | |
| ₩185,900 | 0 | 0.0% | ₩190,800 | ₩192,700 | ₩183,800 | 115,593 |
Splits
2 splits since 2018 · KRX:087010 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 20-for-19 | Split | |
| 2-for-1 | Split |
- Ticker
- KRX:087010
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Peptron, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
Valuation
EV/sales 211× against a median of 9.2×: 7th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩1.27T KRW
- P/E
- Loss
- EV/sales
- 211×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 10.2×
- Gross margin
- −4.5%
- Operating margin
- −427.5%
- Net margin
- −342.2%
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Peptron, Inc. · KRX:087010 | US$985.3M | US$948.0M | n/a | 211× | n/a | 10.2× | −342.2% | 0.2× | n/a |
| Mabwell (Shanghai) Bioscience Co., Ltd. Class A · SSE:688062 | US$1.02B | US$984.8M | n/a | 9.2× | n/a | 9.5× | −146.4% | 2.9× | n/a |
| SpyGlass Pharma, Inc. · NASDAQ:SGP | US$1.02B | US$809.5M | n/a | n/a | n/a | 4.8× | n/a | 0.0× | 1.01 |
| Alto Neuroscience, Inc. · NYSE:ANRO | US$1.02B | US$711.7M | n/a | n/a | n/a | 3.4× | n/a | 0.1× | 1.65 |
| Inhibrx Biosciences, Inc. · NASDAQ:INBX | US$1.02B | US$1.09B | n/a | 546× | n/a | n/a | n/a | n/a | 1.89 |
| Duality Biotherapeutics, Inc. · HKEX:9606 | US$992.3M | US$609.0M | n/a | 4.8× | n/a | 4.6× | −170.8% | 0.3× | n/a |
| Omeros Corporation · NASDAQ:OMER | US$983.7M | US$920.3M | 10.0× | 12.4× | n/a | n/a | 132.3% | n/a | 1.64 |
| Everest Medicines Ltd. · HKEX:1952 | US$981.5M | US$1.00B | n/a | 2.8× | 183× | 1.3× | −2.2% | 0.4× | n/a |
| HBM Holdings Ltd. · HKEX:2142 | US$981.4M | US$711.5M | 10.7× | 4.5× | 8.6× | 2.4× | 57.8% | 0.2× | n/a |
| City Therapeutics, Inc. · NASDAQ:CTY | US$972.4M | US$802.8M | n/a | 59.2× | n/a | n/a | −431.4% | n/a | n/a |
| Seaport Therapeutics, Inc. · NASDAQ:SPTX | US$966.2M | US$675.8M | n/a | n/a | n/a | 2.4× | n/a | 0.0× | 0.72 |
| Median of the others | US$988.0M | US$806.2M | 10.4× | 9.2× | 95.9× | 3.4× | −74.3% | 0.2× | 1.64 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | May 13, 2026 · Before open | −7.0% |
| Q4 2025 | Mar 18, 2026 · Before open | +5.5% |
| Q3 2025 | Nov 12, 2025 · Before open | +10.5% |
| Q2 2025 | Aug 12, 2025 · Before open | +1.8% |
| Q1 2025 | May 15, 2025 · Before open | +1.5% |
| Q4 2024 | Mar 18, 2025 · After close | −4.0% |
| Q3 2024 | Nov 12, 2024 · After close | −6.3% |
| Q2 2024 | Aug 14, 2024 · After close | −7.2% |
| Q1 2024 | May 16, 2024 · After close | +1.9% |
| Q4 2023 | Mar 20, 2024 · After close | +3.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2023 | Nov 14, 2023 · After close | +0.6% |
| Q2 2023 | Aug 11, 2023 · After close | −3.6% |
| Q1 2023 | May 15, 2023 · After close | −2.4% |
| Q4 2022 | Mar 17, 2023 · After close | +0.5% |
| Q3 2022 | Nov 14, 2022 · After close | +1.8% |
| Q2 2022 | Aug 16, 2022 · Before open | −0.2% |
| Q1 2022 | May 13, 2022 · Before open | −0.1% |
| Q4 2021 | Feb 4, 2022 · Before open | +0.3% |
| Q3 2021 | Nov 15, 2021 | −1.0% |
| Quarter to Jun 30, 2021 | Aug 13, 2021 | −5.8% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.63B | 3.15B | 3.34B | 5.81B | 6.62B | 3.12B | 1.80B | 3.86B | 3.22B | 3.13B |
| Cost of revenue | 4.10B | 2.04B | 2.20B | 2.49B | 2.08B | 1.98B | 1.14B | 2.41B | 2.00B | 1.91B |
| Gross profit | 1.53B | 1.11B | 1.14B | 3.32B | 4.54B | 1.14B | 656.6M | 1.45B | 1.22B | 1.22B |
| Research and development | 15.4B | 12.1B | 11.4B | 13.4B | 14.8B | 14.2B | 9.84B | 6.07B | 3.74B | 2.77B |
| Selling, general and administrative | 3.81B | 5.09B | 5.30B | 4.91B | 5.08B | 4.32B | 3.33B | 3.13B | 2.12B | 1.90B |
| Operating income | -21.3B | -16.5B | -15.9B | -15.2B | -15.7B | -17.8B | -12.7B | -7.91B | -4.95B | -3.56B |
| Depreciation and amortization | 2.71B | 2.57B | 2.78B | 4.95B | 3.51B | 3.27B | 2.65B | 899.5M | 594.2M | 340.2M |
| EBITDA | -18.5B | -14.0B | -13.1B | -10.3B | -12.2B | -14.5B | -10.1B | -7.01B | -4.36B | -3.22B |
| Interest expense | 1.32B | 472.9M | 396.0M | 279.7M | 36.8M | 0 | 0 | 0 | 0 | 0 |
| Income before tax | -14.3B | -21.6B | -15.9B | -15.1B | -15.3B | -18.3B | -17.6B | -3.70B | -4.47B | -3.10B |
| Income tax | -241.8M | 46.8M | 91.4M | 28.9M | -46.0M | 94.7M | ||||
| Net income | -13.8B | -22.0B | -15.9B | -15.1B | -15.0B | -18.4B | -17.7B | -3.73B | -4.43B | -3.19B |
| Earnings per share, basic | -594.74 | -948.77 | -774.68 | -730.25 | -729.24 | -891.16 | -1,099.27 | -231.17 | -283.73 | -242.63 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.38B | 1.05B | 4.26B | 5.04B | 4.64B | 68.0B | 2.45B | 1.80B | 955.9M | 3.53B |
| Short-term investments | 102.5B | 122.9B | 718.3M | 12.2B | 25.6B | 2.63B | 15.1B | 25.0B | 15.2B | 32.2B |
| Receivables | 611.6M | 331.3M | 414.8M | 370.9M | 387.5M | 412.1M | 129.1M | 394.8M | 900.3M | 419.3M |
| Inventory | 1.77B | 257.5M | 172.2M | 813.5M | 704.9M | 104.6M | 24.1M | 25.1M | 485.9M | 237.2M |
| Current assets | 115.3B | 126.5B | 7.97B | 23.3B | 32.7B | 72.1B | 18.9B | 31.8B | 23.1B | 49.1B |
| Property, plant and equipment | 40.7B | 38.1B | 40.8B | 40.3B | 37.9B | 28.5B | 7.09B | |||
| Total assets | 179.0B | 168.9B | 52.5B | 68.3B | 77.9B | 117.7B | 61.0B | 71.8B | 53.0B | 57.9B |
| Accounts payable | 692.1M | 478.2M | 223.3M | 641.7M | 571.6M | 725.4M | 522.2M | 209.8M | 144.7M | 102.0M |
| Current liabilities | 7.01B | 5.10B | 6.88B | 10.8B | 6.60B | 28.6B | 1.13B | 2.96B | 733.3M | 924.3M |
| Long-term debt | 25.6B | 8.06B | 4.50B | 0 | 6.05B | 9.05B | 29.1B | 21.9B | 2.00B | 2.00B |
| Total debt | 9.14B | 29.2B | 2.00B | 2.00B | ||||||
| Total liabilities | 37.0B | 17.2B | 16.4B | 15.2B | 15.6B | 40.6B | 32.9B | 26.7B | 4.10B | 4.69B |
| Shareholders' equity | 142.0B | 151.7B | 36.1B | 53.1B | 62.3B | 77.1B | 28.1B | 45.1B | 48.9B | 53.2B |
| Shares outstanding | 23.2M | 23.2M | 20.6M | 20.6M | 20.6M | 20.6M | 16.1M | 16.1M | 15.6M | 13.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -20.6B | -12.8B | -11.0B | -11.7B | -10.6B | -13.6B | -9.60B | -4.18B | -5.63B | -2.73B |
| Capital spending | -3.00B | -1.41B | -868.5M | -1.72B | -698.6M | -3.10B | -5.01B | -10.1B | -21.8B | -2.98B |
| Free cash flow | -23.6B | -14.9B | -13.0B | -13.4B | -11.4B | -16.7B | -16.3B | -14.3B | -27.5B | -5.71B |
| Cash from investing | -127.4B | 11.0B | 12.1B | -25.9B | 5.48B | 9.20B | -20.5B | 3.27B | -33.4B | |
| Cash from financing | 136.8B | -852.5M | -47.8M | -26.9B | 73.6B | 1.03B | 25.5B | -74.2M | 39.2B | |
| Share buybacks | 139.1B | -891.1M | 0 | 68.9B | 39.5B | |||||
| Change in cash | 3.33B | -3.22B | -775.1M | 401.9M | -63.3B | 65.5B | 649.7M | 838.8M | -2.58B | 2.94B |
Cap table
Built by 6ix from Peptron, Inc.’s releases
- Common shares
- 15,326,500
- Fully diluted
- 15,326,500
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 15,326,500 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 15,326,500 |
Log in to ask 6ix AI your own questions about Peptron, Inc.